Source · Select Committees · Health and Social Care Committee
Recommendation 10
10
Commission an independent review of the medicines supply chain, including resilience and generic availability.
Recommendation
The Government should commission an independent review of the medicines supply chain. Given the impact that shortages are having, this should be commissioned as soon as possible and completed within 6 months of starting. The review should assess, and suggest ways of improving, the resilience of the supply chain, the performance and role of the MHRA and the impact of prices paid for medicines and community pharmacy reimbursement mechanisms. We recommend a particular focus on the availability and use of generic medicines, though the review should not be limited to these. (Paragraph 64) Extending pharmacy services
Government Response
A response document is linked to this report, dated 10 January 2025. Response attribution to this recommendation has not been verified. Read the response document ↗